DE69217763D1 - Hexapeptide - Google Patents
HexapeptideInfo
- Publication number
- DE69217763D1 DE69217763D1 DE69217763T DE69217763T DE69217763D1 DE 69217763 D1 DE69217763 D1 DE 69217763D1 DE 69217763 T DE69217763 T DE 69217763T DE 69217763 T DE69217763 T DE 69217763T DE 69217763 D1 DE69217763 D1 DE 69217763D1
- Authority
- DE
- Germany
- Prior art keywords
- agent
- alkyl group
- isoleucine
- valine
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000004475 Arginine Substances 0.000 abstract 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 2
- 229960000310 isoleucine Drugs 0.000 abstract 2
- 239000004474 valine Substances 0.000 abstract 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 230000003501 anti-edematous effect Effects 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 230000000703 anti-shock Effects 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 239000003357 wound healing promoting agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21141691 | 1991-07-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69217763D1 true DE69217763D1 (de) | 1997-04-10 |
| DE69217763T2 DE69217763T2 (de) | 1997-07-10 |
Family
ID=16605597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69217763T Expired - Fee Related DE69217763T2 (de) | 1991-07-30 | 1992-07-30 | Hexapeptide |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5393740A (de) |
| EP (1) | EP0526192B1 (de) |
| JP (1) | JP2803477B2 (de) |
| KR (1) | KR100251496B1 (de) |
| AT (1) | ATE149518T1 (de) |
| AU (1) | AU661003B2 (de) |
| CA (1) | CA2074967A1 (de) |
| DE (1) | DE69217763T2 (de) |
| DK (1) | DK0526192T3 (de) |
| ES (1) | ES2101037T3 (de) |
| GR (1) | GR3023058T3 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995007705A1 (en) * | 1993-09-15 | 1995-03-23 | The Regents Of The University Of California | Method for inhibiting vascular leakage and anti-inflammatory compounds |
| US5955430A (en) * | 1993-09-24 | 1999-09-21 | University Of Southern California | Use of angiotensin II fragments and analogs thereof in tissue repair |
| JPH0848634A (ja) * | 1994-08-05 | 1996-02-20 | Akio Okamoto | 角膜治療剤 |
| GB9425582D0 (en) * | 1994-12-19 | 1995-02-15 | Iaf Biochem Int | Peptides having immunomodulatory activity |
| EP1067950B1 (de) | 1998-04-10 | 2008-05-14 | Mayo Foundation For Medical Education And Research | Neo-tryptophan |
| US7087575B2 (en) * | 2002-07-18 | 2006-08-08 | Mayo Foundation For Medical Education And Research | Treating the effect of nicotine |
| AU2005265164A1 (en) * | 2004-06-17 | 2006-01-26 | Musc Foundation For Research Development | Non-natural amino acids |
| WO2006085417A1 (ja) * | 2005-02-10 | 2006-08-17 | Nagase Chemtex Corporation | 生活習慣病を予防する食品 |
| WO2007100718A2 (en) * | 2006-02-24 | 2007-09-07 | Denise Barbut | Neurotensin receptor agonists and opioid receptor agonists |
| WO2010085661A1 (en) * | 2009-01-23 | 2010-07-29 | Musc Foundation For Reasearch Development | Modified peptides and their use |
| EP2895186A4 (de) * | 2012-09-04 | 2016-05-18 | Univ Leland Stanford Junior | Therapeutische zusammensetzungen und zugehörige verfahren |
| CN105541642A (zh) * | 2016-01-11 | 2016-05-04 | 罗梅 | 一种手性（s）-亮氨醇盐酸盐的合成方法 |
| CZ309857B6 (cs) * | 2022-03-31 | 2023-12-20 | Contipro A.S. | Hexapeptid, kompozice zahrnující tento hexapeptid a jejich topické použití |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4411890A (en) * | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4110321A (en) | 1976-07-12 | 1978-08-29 | Folkers Karl | Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity |
| US4425269A (en) * | 1982-06-07 | 1984-01-10 | Merck & Co., Inc. | Metabolically protected analogs of neurotensin |
| IT1190389B (it) * | 1985-09-19 | 1988-02-16 | Eniricerche Spa | Esapeptidi ad attivita' ipotensiva |
| FI890918A (fi) * | 1988-03-11 | 1989-09-12 | Eisai Co Ltd | Polypeptider. |
| JP2714425B2 (ja) * | 1988-03-11 | 1998-02-16 | エーザイ株式会社 | ポリペプチド |
-
1992
- 1992-07-28 US US07/920,878 patent/US5393740A/en not_active Expired - Fee Related
- 1992-07-30 AU AU20657/92A patent/AU661003B2/en not_active Ceased
- 1992-07-30 EP EP92306942A patent/EP0526192B1/de not_active Expired - Lifetime
- 1992-07-30 JP JP4203816A patent/JP2803477B2/ja not_active Expired - Lifetime
- 1992-07-30 DK DK92306942.1T patent/DK0526192T3/da active
- 1992-07-30 AT AT92306942T patent/ATE149518T1/de not_active IP Right Cessation
- 1992-07-30 ES ES92306942T patent/ES2101037T3/es not_active Expired - Lifetime
- 1992-07-30 CA CA002074967A patent/CA2074967A1/en not_active Abandoned
- 1992-07-30 KR KR1019920013692A patent/KR100251496B1/ko not_active IP Right Cessation
- 1992-07-30 DE DE69217763T patent/DE69217763T2/de not_active Expired - Fee Related
-
1997
- 1997-04-08 GR GR970400726T patent/GR3023058T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2101037T3 (es) | 1997-07-01 |
| US5393740A (en) | 1995-02-28 |
| JP2803477B2 (ja) | 1998-09-24 |
| AU2065792A (en) | 1993-02-04 |
| AU661003B2 (en) | 1995-07-13 |
| ATE149518T1 (de) | 1997-03-15 |
| EP0526192A3 (en) | 1993-12-08 |
| DE69217763T2 (de) | 1997-07-10 |
| KR930002373A (ko) | 1993-02-23 |
| EP0526192A2 (de) | 1993-02-03 |
| JPH05194590A (ja) | 1993-08-03 |
| KR100251496B1 (ko) | 2000-05-01 |
| GR3023058T3 (en) | 1997-07-30 |
| CA2074967A1 (en) | 1993-01-31 |
| EP0526192B1 (de) | 1997-03-05 |
| DK0526192T3 (da) | 1997-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69217763D1 (de) | Hexapeptide | |
| KR930004280A (ko) | 경구 활성 엘라스타제 억제제 | |
| US4692459A (en) | Anti-hypertensive agents | |
| IL129238A0 (en) | N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds | |
| TR200100438T2 (tr) | Hepatit C inhibitörü peptitler | |
| ES2164218T3 (es) | Derivados de camptotecina. | |
| NO911787D0 (no) | Peptidaminer samt fremgangsmaate for fremstilling derav. | |
| DE69810283D1 (de) | GnRH ANTAGONISTEN | |
| NZ334906A (en) | A sulphonamido pentanoic acid derivative useful as an interleukin-1-beta converting enzyme inhibitor | |
| FI824419L (fi) | Cykliska oktapeptider och farmaceutiska preparat daerav, samt foerfarande foer deras framstaellningderas anvaendning | |
| AR006523A1 (es) | Compuestos ciclicos, inhibidores de la adhesion | |
| DE69013742D1 (de) | Peptide und diese Peptide enthaltende Wirkstoffe gegen Dementia. | |
| ES2193272T3 (es) | Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen. | |
| HU9301520D0 (en) | Methods for producing cyclopeptides promoting absorption of peptides and albumins through mucous membrane as well as pharmaceutical preparations containing said compounds as auxiliary agents | |
| KR910002899A (ko) | 혈조절 펩타이드 | |
| KR940007059A (ko) | 변형된 혈소판 인자-4 | |
| DE68923572D1 (de) | Peptide. | |
| GB1489326A (en) | Pharmaceutically active polypeptides | |
| BR0014803A (pt) | Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico | |
| KR970704462A (ko) | 각막치료제(corneal therapeutic agent) | |
| CO5611158A2 (es) | Metodos y composiciones para tratar toxicidad gastrointestinal inducida por terapia citoablativa | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
| DE60137340D1 (de) | Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen | |
| FI944224A0 (fi) | C-reaktiivisten proteiinifragmenttien osittain modifioidut ja retroinvertoidut tetrapeptidianalogit | |
| IT1196502B (it) | Analoghi parzialmente retro invertiti della tuftsina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |